Threshold Pharmaceuticals (THLD)
Create an AlertThreshold Pharmaceuticals News
Threshold Pharmaceuticals: A Biotech That Investors Need To Know About
Fool Jun 14Threshold Pharmaceuticals: A Biotech That Investors Need To Know About
Celgene Soars in 2013; What Does the Future Hold?
Fool Jun 6Celgene Soars in 2013; What Does the Future Hold?
Threshold Pharmaceuticals Announces Data From Two Ongoing Phase 1/2 Trials of TH-302 at the 2013 ASCO Annual Meeting
Marketwired Jun 2Threshold Pharmaceuticals, Inc. today announced data from two ongoing Phase 1/2 trials evaluating TH-302, an investigational hypoxia-targeted drug, at the 49th Annual Meeting of the American Society of ...
Commit To Buy Threshold Pharmaceuticals At $2.50, Earn 16%
May 24Investors eyeing a purchase of Threshold Pharmaceuticals Inc stock, but cautious about paying the going market price of $5.51/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the January 2015 put at the $2.50 strike, which has a bid at the time of this writing of 40 cents.
Threshold Pharmaceuticals Announces Presentations and Webcasts at Three Upcoming Investor Conferences
Marketwired May 9Threshold Pharmaceuticals, Inc. today announced that Barry Selick, Ph.D., Threshold's Chief Executive Officer, will present a company overview at three upcoming investor conferences:
Threshold Pharmaceuticals (THLD) Posts Q1 Loss of 16c/Share
Street Insider May 2Threshold Pharmaceuticals Reports First Quarter 2013 Financial and Operational Results
Marketwired May 2Threshold Pharmaceuticals, Inc. , today reported financial results for the first quarter 2013. Revenue for the first quarter ended March 31, 2013 was $2.9 million. The operating loss for the first quarter ...
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| THLD | 5.50 | +0.00 | +0.00% | 311.01M |
